News & Insights

Blessina (“Blessi”) Kumar is CEO of the Global Coalition of TB Advocates (GCTA). For nearly two decades, she has championed a people-centred, rights-based approach to tuberculosis (TB), focusing on ensuring that people affected by TB are included in decisions that shape policies and programmes.

At this year’s Union World Conference on Lung Health in Copenhagen, AJ Vaccines had the privilege of speaking with Ani Herna Sari – a two-time tuberculosis (TB) survivor, advocate and chairperson of Rekat Peduli Indonesia, who also works with The Global Fund.

While advances in diagnostics and treatment have made significant progress, one critical barrier to seeking medical attention remains the: stigma around this infectious disease.

AJ Vaccines is proud to be a commercial partner in the development of the world's first vaccine against Hepatitis C - a breakthrough with the potential to save millions of lives globally.

Read the news from Innovation Fund Denmark.